{"id":"https://openalex.org/W1985014198","doi":"https://doi.org/10.1145/1570256.1570382","title":"A PSO/ACO approach to knowledge discovery in a pharmacovigilance context","display_name":"A PSO/ACO approach to knowledge discovery in a pharmacovigilance context","publication_year":2009,"publication_date":"2009-07-08","ids":{"openalex":"https://openalex.org/W1985014198","doi":"https://doi.org/10.1145/1570256.1570382","mag":"1985014198"},"language":"en","primary_location":{"id":"doi:10.1145/1570256.1570382","is_oa":false,"landing_page_url":"https://doi.org/10.1145/1570256.1570382","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the 11th Annual Conference Companion on Genetic and Evolutionary Computation Conference: Late Breaking Papers","raw_type":"proceedings-article"},"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050880128","display_name":"Margarita Sordo","orcid":null},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Margarita Sordo","raw_affiliation_strings":["Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA","Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA,"],"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090624529","display_name":"Gabriela Ochoa","orcid":"https://orcid.org/0000-0001-7649-5669"},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gabriela Ochoa","raw_affiliation_strings":["School of Computer Science, University of Nottingham, Nottingham, United Kingdom","[School of Computer Science, University of Nottingham, Nottingham, United Kingdom]"],"affiliations":[{"raw_affiliation_string":"School of Computer Science, University of Nottingham, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I142263535"]},{"raw_affiliation_string":"[School of Computer Science, University of Nottingham, Nottingham, United Kingdom]","institution_ids":["https://openalex.org/I142263535"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087242254","display_name":"Shawn N. Murphy","orcid":"https://orcid.org/0000-0002-1905-8806"},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shawn N. Murphy","raw_affiliation_strings":["Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA","Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA,"],"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5050880128"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":null,"apc_paid":null,"fwci":1.3164,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.79884868,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":null,"issue":null,"first_page":"2679","last_page":"2684"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9983000159263611,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9983000159263611,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9969000220298767,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9940000176429749,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"Pharmacovigilance","score":0.8652446866035461},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"Rosiglitazone","score":0.8323025703430176},{"id":"https://openalex.org/keywords/context","display_name":"Context (archaeology)","score":0.6989739537239075},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.6579898595809937},{"id":"https://openalex.org/keywords/adverse-effect","display_name":"Adverse effect","score":0.6360206604003906},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"Pioglitazone","score":0.5345714688301086},{"id":"https://openalex.org/keywords/postmarketing-surveillance","display_name":"Postmarketing surveillance","score":0.45934730768203735},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"Myocardial infarction","score":0.4488629400730133},{"id":"https://openalex.org/keywords/pharmacology","display_name":"Pharmacology","score":0.35175520181655884},{"id":"https://openalex.org/keywords/intensive-care-medicine","display_name":"Intensive care medicine","score":0.3463832139968872},{"id":"https://openalex.org/keywords/data-mining","display_name":"Data mining","score":0.32800811529159546},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"Diabetes mellitus","score":0.3272799551486969},{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.27772027254104614},{"id":"https://openalex.org/keywords/internal-medicine","display_name":"Internal medicine","score":0.23032686114311218},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"Type 2 diabetes","score":0.17184096574783325}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.8652446866035461},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.8323025703430176},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6989739537239075},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6579898595809937},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6360206604003906},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.5345714688301086},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.45934730768203735},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.4488629400730133},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35175520181655884},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3463832139968872},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.32800811529159546},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3272799551486969},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.27772027254104614},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23032686114311218},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.17184096574783325},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1145/1570256.1570382","is_oa":false,"landing_page_url":"https://doi.org/10.1145/1570256.1570382","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the 11th Annual Conference Companion on Genetic and Evolutionary Computation Conference: Late Breaking Papers","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6700000166893005,"display_name":"Good health and well-being"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W178924345","https://openalex.org/W1587113570","https://openalex.org/W1599621040","https://openalex.org/W1976878146","https://openalex.org/W1987941106","https://openalex.org/W1995528018","https://openalex.org/W2002078774","https://openalex.org/W2025266397","https://openalex.org/W2038932922","https://openalex.org/W2057764978","https://openalex.org/W2059838070","https://openalex.org/W2064187930","https://openalex.org/W2095127972","https://openalex.org/W2102524066","https://openalex.org/W2110424396","https://openalex.org/W2119567793","https://openalex.org/W2125827301","https://openalex.org/W2127125241","https://openalex.org/W2139906414","https://openalex.org/W2146055458","https://openalex.org/W2148359829","https://openalex.org/W2158968701","https://openalex.org/W2159584910","https://openalex.org/W2159969745","https://openalex.org/W2165832533","https://openalex.org/W2287618478","https://openalex.org/W2331274940","https://openalex.org/W4233464183","https://openalex.org/W4240449862","https://openalex.org/W4241041535","https://openalex.org/W4253462034","https://openalex.org/W4298491736"],"related_works":["https://openalex.org/W2354249222","https://openalex.org/W3029800468","https://openalex.org/W2020625666","https://openalex.org/W2172062051","https://openalex.org/W2340355954","https://openalex.org/W2166665398","https://openalex.org/W2110102664","https://openalex.org/W2107966736","https://openalex.org/W1964594176","https://openalex.org/W2007384705"],"abstract_inverted_index":{"We":[0],"propose":[1],"and":[2,17,46,48,74,100,116],"evaluate":[3],"the":[4,21,49,63,79,88,125,131,155],"use":[5],"of":[6,23,36,51,65,130,144],"a":[7,32,140,166],"Particle":[8],"Swarm":[9],"Optimization/Ant":[10],"Colony":[11],"Optimization":[12],"(PSO/ACO)":[13],"methodology":[14],"for":[15],"classification":[16,86,105],"rule":[18],"discovery":[19],"in":[20],"context":[22],"medication":[24,76],"postmarketing":[25],"surveillance":[26],"or":[27],"pharmacovigilance.":[28],"Our":[29,104],"study":[30],"considers":[31],"large":[33],"data":[34],"set":[35],"diabetic":[37],"patients":[38],"on":[39,148,172],"two":[40],"widely":[41],"used":[42],"antidiabetic":[43,133],"drugs":[44,134],"(rosiglitazone":[45],"pioglitazone),":[47],"risk":[50,98,143],"myocardial":[52,170],"infarction":[53,171],"as":[54,152],"an":[55,101,145],"adverse":[56,75,102,146],"effect.":[57],"The":[58,118],"goal":[59],"is":[60,82],"to":[61,84,138,154],"determine":[62],"presence":[64],"previously":[66],"undetected":[67],"causal":[68],"relationships":[69],"between":[70,97],"therapeutics,":[71],"patient":[72],"characteristics,":[73],"outcomes.":[77],"Since":[78],"proposed":[80],"approach":[81],"able":[83],"discover":[85],"rules,":[87],"elicited":[89,119],"knowledge":[90],"may":[91,164],"suggest":[92],"new":[93],"hypotheses":[94],"regarding":[95],"associations":[96],"factors":[99],"event.":[103],"results":[106],"show":[107],"high":[108],"accuracy.":[109],"Furthermore,":[110],"several":[111],"medication-related":[112],"rules":[113,120],"were":[114],"discovered":[115],"analyzed.":[117],"support":[121],"previous":[122],"studies":[123],"from":[124],"medical":[126],"literature.":[127],"Moreover,":[128],"one":[129],"studied":[132],"(rosiglitazone)":[135],"was":[136],"found":[137],"have":[139,165],"significant":[141],"higher":[142],"event":[147],"diabetic,":[149,173],"hypertensive":[150,174],"patients,":[151],"compared":[153],"other":[156],"drug.":[157],"This":[158],"last":[159],"finding":[160],"suggests":[161],"that":[162],"pioglitazone":[163],"protective":[167],"effect":[168],"against":[169],"patients.":[175]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2025-10-10T00:00:00"}